Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Sima Ehsani Chimeh
Assistant Clinical Professor, Medicine - (Clinical Series Track)
Medicine
Full Page
Overview
Research
More
Collaboration
(30)
Terry Badger
Mutual work: 2 Grants
Collaboration Details
Jessica Rainbow
Mutual work: 1 Grant
Collaboration Details
Mohab Ibrahim
Mutual work: 1 Publication
Collaboration Details
Todd Vanderah
Mutual work: 1 Publication
Collaboration Details
Denise Roe
Mutual work: 4 Publications
Collaboration Details
Page 1 of 6
Previous page
Next page
Grants
(15)
A Randomized Phase 2 Non-inferiority Trial of (Z)-endoxifen and Exemestane + Goserelin as Neoadjuvant Treatment in Premenopausal Women with ER+/HER2- Breast Cancer
Active
·
2024
·
$300.6K
·
External
Principal Investigator (PI)
breast cancer,
neoadjuvant treatment,
randomized trial,
hormone therapy,
pre-menopausal
EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant Vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for
Active
·
2024
·
$252.6K
·
External
Principal Investigator (PI)
breast cancer,
adjuvant therapy,
immunotherapy,
clinical trial,
hormone receptor
Phase 3, Open-Label, Randomized Study of Datopotamab Deruxtecan with or without Durvalumab Versus Investigator's Choice of Therapy in Patients with Stage I-III Triple Negative Breast Cancer who have R
Active
·
2023
·
$0 / $709.8K
·
External
Co-Investigator (COI)
breast cancer,
immunotherapy,
clinical trials,
combination therapy,
precision medicine
An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of
Active
·
2023
·
$0 / $342.9K
·
External
Co-Investigator (COI)
cancer treatment,
drug combination,
efficacy,
safety
A Phase II Study of Ribociclib and Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study)
Active
·
2023
·
$150.2K
·
External
Principal Investigator (PI)
breast cancer,
endocrine therapy,
clinical trial,
recurrence,
her2 negative
Page 1 of 3
Previous page
Next page
Publications
(13)
Recent
A Pilot Intervention to Understand Primary Care Physicians' Perspectives towards SurvivorshiCare to Improve Communication between Primary Care and Oncology.
2022
oncology,
primary care,
communication,
survivorship,
intervention
Feasibility Trial to Evaluate Tendon Stiffness Obtained from Shear Wave Elastography Imaging as a Biomarker of Aromatase Inhibitor-Induced Arthralgias
2022
biomarker,
tendon stiffness,
feasibility trial,
shear wave elastography,
aromatase inhibitor
Precision medicine journey through omics approach
2021
precision medicine,
omics approach,
personalized treatment,
genomics,
biomarker identification
Genomic medicine on the frontier of precision medicine
2021
genomic medicine,
precision medicine,
frontier research,
healthcare innovation,
personalized treatment
Abstract P3-08-27: Imaging predictors for development of chemotherapy induced peripheral neuropathy
2020
imaging,
predictors,
chemotherapy,
peripheral neuropathy,
development
Diffuse tensor imaging of lower extremities: a novel MR imaging technique for chemotherapy-induced peripheral neuropathy
2020
medical imaging,
neuropathy,
chemotherapy,
lower extremities,
research techniques
Oncologic Outcomes with Neoadjuvant chemotherapy and breast conservation for MRI Occult breast cancer
2018
oncologic outcomes,
neoadjuvant chemotherapy,
breast conservation,
mri occult breast cancer,
cancer treatment
Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive HR+ metastatic breast cancer
2017
breast cancer,
hormone receptor,
metastatic,
oncology,
clinical trial
Genomic Testing in the Management of Early-Stage Breast Cancer
2017
genomics,
breast cancer,
cancer management,
precision medicine,
molecular diagnostics
Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer
2015
breast cancer screening,
magnetic resonance imaging,
patient outcomes,
high-risk patients,
cancer risk assessment